Where does Acorda Therapeutics, Inc. rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Acorda Therapeutics, Inc. ranks #7,359 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Acorda Therapeutics, Inc. hold?

Acorda Therapeutics, Inc. holds 44 US utility patents granted between 2015 and 2024, spanning 10 technology areas.

What is Acorda Therapeutics, Inc.'s Innovation Score?

Acorda Therapeutics, Inc. has an Innovation Score of 33.4 out of 100 (44th percentile of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

What technology areas does Acorda Therapeutics, Inc. focus on?

Acorda Therapeutics, Inc.'s top technology area is A61K (Preparations FOR Medical, Dental OR Toiletry Purposes) with 43 patents, ranking #519 of 7,163 assignees active in that subclass. Grants appear in 10 CPC subclasses total.

Is Acorda Therapeutics, Inc.'s patent grant rate increasing or decreasing?

Acorda Therapeutics, Inc.'s recent grant velocity is -74% compared to the prior five-year period (grant years, not application filing dates). Grant activity has slowed relative to earlier years.

What does claim depth mean for Acorda Therapeutics, Inc.'s patents?

Acorda Therapeutics, Inc.'s patents average 13.3 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Acorda Therapeutics, Inc. patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView US Corporation

Acorda Therapeutics, Inc.

USPTO PatentsView assignee record - 44 granted patents across 10 technology areas, recorded in grant years 2015–2024. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61K (Preparations FOR Medical, Dental OR Toiletry Purposes).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Acorda ranks #7,359 of 49,997 tracked US assignees by granted-patent volume, with 44 patents across 10 technology areas.

#7,359
of 49,997 US assignees by volume: 44th percentile
by Innovation Score (33.4/100): 13.3
avg claims per patent: -74%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R7359 · US Corporation #7,359 · 44 grants

GRANTS-SMALL · UPPER-Q · PHOTO-FINISH · CPC-FOCUS · INNOV-THIN · CLAIMS-RICH · TYPE-USCORP · VEL-DROP · BOOK-FULL

GRANTS-SMALL 44 grants
UPPER-Q #7,359/49,997
PHOTO-FINISH Accuride International
CPC-FOCUS A61K · 10 areas
INNOV-THIN 33.4/100
CLAIMS-RICH 13.3 claims/avg
TYPE-USCORP US Corporation
VEL-DROP -74% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: Accuride International GmbH (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Acorda’s 33.4 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 13.1 pts (39%) Velocity 1.1 pts (3%) Breadth 11.2 pts (34%) Claim depth 8.0 pts (24%)

Qualcomm Incorporated · highest

85
Evga · near

33
Acorda Therapeutics · this assignee

33
Fuji Seiko · near

33
Green Creative · near

33
Wireless Environment · near

33
3D Lighting… · lowest

7

What this shows Acorda's Innovation Score is 33.4/100 (44th percentile of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for Acorda?

Each dot is one of Acorda’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Acorda’s own 13.3 claims/patent is at or below the 17.9 median for these volume peers. Volume here does not track with deeper claims; several lower-volume peers claim more thoroughly per patent.

Acorda vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Acorda's grants concentrate

Acorda Therapeutics, Inc. is a focused PatentsView assignee: 10 CPC subclasses with 97.7% of grants classified under A61K (Preparations FOR Medical, Dental OR Toiletry Purposes). Peak complete grant year is 2016 (8 grants) versus a trough of 1 in 2022. By volume, Acorda sits between Automotive Energy Supply Corporation and AmRad Manufacturing, LLC.

Acorda's three-year grant acceleration

Acorda Therapeutics, Inc. shows 2 grants in 2022–2024 against only 12 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Automotive Energy…

44
AVL Powertrain En…

44
Axcess Global Sci…

44
Accuride Internat…

44
Leader Technology

44
Agbiome

44
Agility Fuel Syst…

44
Amrad Manufacturi…

44
Acorda Therapeuti… ◀

44

What this shows Acorda holds 44 patents at rank #7,368, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Acorda

By rank, the assignees closest to #7,368 in granted patent volume.

Leaders in A61K (Preparations FOR Medical)

Other assignees with the most granted patents in Acorda's primary technology class.

Assignees with similar portfolio profiles

Two PlainPatent-derived peer sets for Acorda, neither rank-band nor same-CPC leaders (those blocks stay above). In A61K (Preparations FOR Medical), Acorda ranks #519 of 7,163 assignees by patent count in that subclass.

Similar innovation score

Nearest assignees by Innovation Score (33 here).

Fuji Seiko Co., Ltd. 33 Wireless Environment, LLC 33 Evga Corporation 33 Green Creative, Ltd 33

Acorda's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

33 44th percentile higher than 44% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2015–2024

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table

Acorda Therapeutics, Inc. patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2015	6	13.6%
2016	8	18.2%
2017	8	18.2%
2018	8	18.2%
2019	5	11.4%
2020	3	6.8%
2021	4	9.1%
2022	1	2.3%
2024	1	2.3%

Which technologies does Acorda Therapeutics, Inc. patent most?

A61K - Preparations FOR Medical, Dental OR Toiletry Purposes 43

A61P - Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations 43

C12N - Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media 13

G01N - Investigating OR Analysing Materials BY Determining Their Chemical OR Physical Properties 10

C12Y - Enzymes 9

C07F - Acyclic, Carbocyclic OR Heterocyclic Compounds Containing Elements Other Than Carbon, Hydrogen, Halogen, Oxygen, Nitrogen, Sulfur, Selenium OR Tellurium 8

C07C - Acyclic OR Carbocyclic Compounds 7

C07K - Peptides 5

A01K - Animal HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; Rearing OR Breeding Animals, NOT Otherwise Provided FOR; NEW Breeds OF Animals 2

A61Q - Specific USE OF Cosmetics OR Similar Toiletry Preparations 1

Top 10 of 10 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

Acorda Therapeutics, Inc.'s patent record in context - here's where to go next.

Acorda Therapeutics, Inc.'s lead technology class is A61K (Preparations FOR Medical, Dental OR Toiletry Purposes), 97.7% of its portfolio - see every assignee active in that class. Explore A61K
Ranked #7,359 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Acorda Therapeutics, Inc. against Automotive Energy Supply Corporation, an assignee filing at a similar volume. Compare portfolios
Innovation Score of 33.4/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.